| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 256 |
| 1 | PREDNISONE | 252 |
| 2 | METHOTREXATE | 231 |
| 3 | FUROSEMIDE | 216 |
| 4 | ACETAMINOPHEN | 211 |
| 5 | PREDNISOLONE | 207 |
| 6 | PREDNISOLONE ORAL | 207 |
| 7 | PREDNISOLONE ORAL SOLUTION | 207 |
| 8 | CYCLOPHOSPHAMIDE | 204 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 204 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM CHLORIDE | 4 | 0.3636 |
| 1 | ISOFLURANE | 64 | 0.0325 |
| 2 | VANCOMYCIN HYDROCHLORIDE | 165 | 0.0197 |
| 3 | CEFTAROLINE FOSAMIL | 12 | 0.0143 |
| 4 | CASPOFUNGIN ACETATE | 18 | 0.0113 |
| 5 | BEVACIZUMAB-ADCD | 2 | 0.0099 |
| 6 | PHENOBARBITAL SODIUM | 4 | 0.0096 |
| 7 | ANIDULAFUNGIN | 15 | 0.0092 |
| 8 | DEFLAZACORT | 23 | 0.0089 |
| 9 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 34 | 0.0075 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 817 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 462 |
| 2 | Benzodiazepine [EPC] | 269 |
| 3 | Alkylating Drug [EPC] | 266 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 256 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 249 |
| 6 | Loop Diuretic [EPC] | 238 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 207 |
| 8 | Proton Pump Inhibitor [EPC] | 191 |
| 9 | Platinum-based Drug [EPC] | 170 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 6 | 0.0087 |
| 1 | Nucleoside Analog Antifungal [EPC] | 7 | 0.0049 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 27 | 0.0046 |
| 3 | Tetracycline-class Antibacterial [EPC] | 33 | 0.0042 |
| 4 | Provitamin D2 Compound [EPC] | 118 | 0.0040 |
| 5 | Nitrofuran Antibacterial [EPC] | 69 | 0.0039 |
| 6 | Carnitine Analog [EPC] | 14 | 0.0038 |
| 7 | Penem Antibacterial [EPC] | 120 | 0.0035 |
| 8 | CD19-directed Chimeric Antigen Receptor [EPC] | 34 | 0.0033 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 42 | 0.0033 |